The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
The FluMist vaccine can now be self-administered after the FDA approved its use to treat the influenza disease.
The Food and Drug Administration announced on Friday an approval of a new self- and caregiver-administered nose spray against ...